| 1 day | +0.52% |
| |||
| 1 week | +1.49% |
| |||
| 4 week | +8.60% |
| |||
| 3 month | +7.66% |
| |||
| YTD | +16.79% |
| |||
| 1 year | +35.20% |
| |||
| 3 years* | +12.83% |
| |||
| 5 years* | +6.08% |
| |||
| *annualized | |||||
| Best 3 month return | +22.23% | |
| Worst 3 month return | -22.75% |
| Return | Risk | Rating | |
| 3 years | Above Average | Above Average |
|
| 5 years | Above Average | Average |
|
| 10 years | Above Average | Average |
|
| Overall | Above Average | Average |
|
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
| Total assets | ||
| Front load | 0.00% | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 0.50% | |
| Fund family | Cazenove Capital Management |
| Cash | 0.05% | |
| Stocks | 96.46% | |
| Bonds | 0.00% | |
| Preferred | 0.01% | |
| Other | 3.48% |
| Initial | �10,000 | |
| Additional | �1,000 | |
| AIP Initial | �0 | |
| AIP Additional | �0 |
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 0.16 | -0.76 | 0.32 | 0.63 | |
| Beta* | 1.07 | 1.09 | 1.02 | 1.02 | |
| Mean annual return | 1.53 | 0.84 | 0.61 | 0.92 | |
| R-squared* | 96.25 | 93.03 | 93.98 | 93.86 | |
| Standard deviation | 11.73 | 14.83 | 17.74 | 14.28 | |
| Sharpe ratio | 1.52 | 0.64 | 0.33 | 0.55 | |
| * Against standard index | |||||
| Security | Net Assets | |
| Bp Plc (BPAQF) | 7.87% | |
| Royal Dutch Shell Plc | 7.79% | |
| Vodafone Group Plc (VODPF) | 7.59% | |
| Glaxo Smith Kline (BIOC.CA) | 6.98% | |
| Hsbc Holdings Plc (HBCYF) | 5.35% | |
| Bg Group Plc (BG.) | 4.27% | |
| AstraZeneca PLC (AZN) | 4.15% | |
| Anglo American Plc (AAUKF) | 3.41% | |
| Xstrata Plc (XTA) | 3.09% | |
| Barclays Plc (BCLYF) | 2.47% |